Has anyone tried low dose naltroxone for prostate cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Low-Dose Naltrexone (LDN) and Prostate Cancer
I appreciate your question about low-dose naltrexone (LDN) for prostate cancer. Let me give you an honest, evidence-based answer.
What the Medical Evidence Shows
LDN is not currently part of standard prostate cancer treatment. When I review the NCCN Guidelines for Prostate Cancer (both early-stage and advanced-stage versions), low-dose naltrexone does not appear as a recommended treatment option for any stage of prostate cancer.
The established treatment approaches for prostate cancer include:
- Active surveillance (for early-stage, low-risk disease)
- Surgery (radical prostatectomy)
- Radiation therapy
- Hormone therapy (androgen deprivation therapy/ADT) - which blocks testosterone that fuels prostate cancer growth
- Chemotherapy (for advanced disease)
- Newer targeted therapies based on specific biomarkers
About Low-Dose Naltrexone
Naltrexone is an FDA-approved medication originally developed for opioid and alcohol dependence. Some patients explore LDN off-label for various conditions based on preliminary research about immune modulation, but:
- No clinical trials have established its effectiveness for prostate cancer
- No major cancer organizations (NCCN, ASCO, American Cancer Society) recommend it for prostate cancer
- Limited human evidence exists for most proposed uses of LDN
What You Should Do
If you're interested in exploring LDN or any complementary approach:
-
Tell your oncologist directly - Don't use it without their knowledge, as it could interact with your current treatment
-
Ask specific questions:
- "Is there any evidence LDN could help my specific situation?"
- "Could LDN interfere with my current treatment plan?"
- "Are there clinical trials I should know about?"
- "What does the research actually show about LDN and prostate cancer?"
-
Look for clinical trials - Visit ClinicalTrials.gov to see if any LDN studies are enrolling prostate cancer patients
-
Stick with evidence-based options - Your oncologist can discuss treatments with proven benefit for your specific stage and risk group
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ